Down-regulation of proinflammatory capacity during apoptosis in human polymorphonuclear leukocytes

Journal of Immunology

Volumn 170, Issue 6, 2003, Pages 3357-3368

  Kobayashi, Scott D ^a   Voyich, Jovanka M ^a   Braughton, Kevin R ^a   DeLeo, Frank R ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ION; CAMPTOTHECIN; CD31 ANTIGEN; CD32 ANTIGEN; CELL ADHESION MOLECULE; CHEMOKINE; CHEMOKINE RECEPTOR CXCR2; COMPLEMENT COMPONENT C1Q; COMPLEMENT RECEPTOR; FAS ANTIGEN; FORMYLPEPTIDE; GROWTH FACTOR; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 10 RECEPTOR; INTERLEUKIN 13 RECEPTOR; INTERLEUKIN 15 RECEPTOR; INTERLEUKIN 16; INTERLEUKIN 17 RECEPTOR; INTERLEUKIN 18 RECEPTOR; INTERLEUKIN RECEPTOR; LOW DENSITY LIPOPROTEIN RECEPTOR; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 3; ONCOSTATIN M; PADGEM PROTEIN; PHOSPHATIDYLINOSITIDE; RNA; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 6; UNCLASSIFIED DRUG; UNINDEXED DRUG;

APOPTOSIS; ARTICLE; BACTERIAL INFECTION; CELL VIABILITY; CONTROLLED STUDY; DNA MICROARRAY; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; HOST RESISTANCE; HUMAN; HUMAN CELL; INFLAMMATION; LEUKOCYTE ACTIVATION; PHAGOCYTOSIS; PHOSPHOINOSITIDE METABOLISM; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

EID: 0037443759     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.170.6.3357     Document Type: Article

References (49)

1. Nauseef, W. M., and R. A. Clark. 2000. Granulocytic phagocytes. In Basic Principles in the Diagnosis and Management of Infectious Diseases. Vol. 1. G. L. Mandel, J. E. Bennett, and R. Dolin, eds. Churchill Livingstone, New York, NY, p. 89.
2. Savill, J. 1997. Apoptosis in the resolution of inflammation. J. Leukocyte Biol. 61:380.
3. Savill, J. S., A. H. Wyllie, J. E. Henson, M. J. Walport, P. M. Henson, and C. Haslett. 1989. Macrophage phagocytosis of aging neutrophils in inflammation: programmed cell death in the neutrophil leads to its recognition by macrophages. J. Clin. Invest. 83:865.
4. Kobayashi, S. D., J. M. Voyich, C. L. Buhl, R. M. Stahl, and F. R. DeLeo. 2002. Global changes in gene expression by human polymorphonuclear leukocytes during receptor-mediated phagocytosis: cell fate is regulated at the level of gene expression. Proc. Natl. Acad. Sci. USA 99:6901.
5. Jones, S. L., F. P. Lindberg, and E. J. Brown. 1999. Phagocytosis. In Fundamental Immunology, 4th Ed. W. F. Paul, ed. Lippincott-Raven, New York, NY, p. 1001.
6. Murphy, P. M., and H. L. Tiffany. 1991. Cloning of complementary DNA encoding a functional human interleukin-8 receptor. Science 253:1280.
7. Abdelilah, S., K. Latifa, N. Esra, L. Cameron, L. Bouchaib, N. Nicolaides, R. Levitt, and Q. Hamid. 2001. Functional expression of IL-9 receptor by human neutrophils from asthmatic donors: role in IL-8 release. J. Immunol. 166:2768.
8. Crepaldi, L., S. Gasperini, J. A. Lapinet, F. Calzetti, C. Pinardi, Y. Liu, S. Zurawski, R. de Waal Malefyt, K. W. Moore, and M. A. Cassatella. 2001. Up-regulation of IL-10R1 expression is required to render human neutrophils fully responsive to IL-10. J. Immunol. 167:2312.
9. Colotta, F., F. Re, M. Muzio, N. Polentarutti, A. Minty, D. Caput, P. Ferrara, and A. Mantovani. 1994. Interleukin-13 induces expression and release of interleukin-1 decoy receptor in human polymorphonuclear cells. J. Biol. Chem. 269:12403.
10. Girard, D., M. E. Paquet, R. Paquin, and A. D. Beaulieu. 1996. Differential effects of interleukin-15 (IL-15) and IL-2 on human neutrophils: modulation of phagocytosis, cytoskeleton rearrangement, gene expression, and apoptosis by IL-15. Blood 88:3176.
11. Musso, T., L. Calosso, M. Zucca, M. Millesimo, M. Puliti, S. Bulfone-Paus, C. Merlino, D. Savoia, R. Cavallo, A. N. Ponzi, and R. Badolato. 1998. Interleukin-15 activates proinflammatory and antimicrobial functions in polymorphonuclear cells. Infect. Immun. 66:2640.
12. Leung, B. P., S. Culshaw, J. A. Gracie, D. Hunter, C. A. Canetti, C. Campbell, F. Cunha, F. Y. Liew, and I. B. McInnes. 2001. A role for IL-18 in neutrophil activation. J. Immunol. 167:2879.
13. Muzio, M., D. Bosisio, N. Polentarutti, G. D'amico, A. Stoppacciaro, R. Mancinelli, C. van't Veer, G. Penton-Rol, L. P. Ruco, P. Allavena, and A. Mantovani. 2000. Differential expression and regulation of Toll-like receptors (TLR) in human leukocytes: selective expression of TLR3 in dendritic cells. J. Immunol. 164:5998.
14. Cassatella, M. A. 1995. The production of cytokines by polymorphonuclear neutrophils. Immunol. Today 16:21.
15. Scapini, P., F. Calzetti, and M. A. Cassatella. 1999. On the detection of neutrophil-derived vascular endothelial growth factor (VEGF). J. Immunol. Methods 232:121.
16. Scapini, P., J. A. Lapinet-Vera, S. Gasperini, F. Calzetti, F. Bazzoni, and M. A. Cassatella. 2000. The neutrophil as a cellular source of chemokines. Immunol. Rev. 177:195.
17. Hirsch, E., V. L. Katanaev, C. Garlanda, O. Azzolino, L. Pirola, L. Silengo, S. Sozzani, A. Mantovani, F. Altruda, and M. P. Wymann. 2000. Central role for G protein-coupled phosphoinositide 3-kinase γ in inflammation. Science 287:1049.
18. phox. Nat. Cell Biol. 3:679.
19. phox bind to lipid products of PI(3)K. Nat. Cell Biol. 3:675.
20. Fruman, D. A., and L. C. Cantley. 2002. Phosphoinositide 3-kinase in immunological systems. Semin. Immunol. 14:7.
21. Baggiolini, M., B. Dewald, and B. Moser. 1997. Human chemokines: an update. Annu. Rev. Immunol. 15:675.
22. Cumock, A. P., M. K. Logan, and S. G. Ward. 2002. Chemokine signalling: pivoting around multiple phosphoinositide 3-kinases. Immunology 105:125.
23. Franke, T. F., D. R. Kaplan, and L. C. Cantley. 1997. PI3K: downstream AKT ion blocks apoptosis. Cell 88:435.
24. Berridge, M. J., P. Lipp, and M. D. Bootman. 2000. The versatility and universality of calcium signalling. Nat. Rev. Mol. Cell. Biol. 1:11.
25. Dudek, H., S. R. Datta, T. F. Franke, M. J. Birnbaum, R. Yao, G. M. Cooper, R. A. Segal, D. R. Kaplan, and M. E. Greenberg. 1997. Regulation of neuronal survival by the serine-threonine protein kinase Akt. Science 275:661.
26. Romashkova, J. A., and S. S. Makarov. 1999. NF-κB is a target of AKT in anti-apoptotic PDGF signalling. Nature 401:86.
27. Ozes, O. N., L. D. Mayo, J. A. Gustin, S. R. Pfeffer, L. M. Pfeffer, and D. B. Donner. 1999. NF-κB activation by tumour necrosis factor requires the Akt serine-threonine kinase. Nature 401:82.
28. Du, K., and M. Montminy. 1998. CREB is a regulatory target for the protein kinase Akt/PKB. J. Biol. Chem. 273:32377.
29. Brunet, A., A. Bonni, M. J. Zigmond, M. Z. Lin, P. Juo, L. S. Hu, M. J. Anderson, K. C. Arden, J. Blenis, and M. E. Greenberg. 1999. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 96:857.
30. Khan, A. A., M. J. Soloski, A. H. Sharp, G. Schilling, D. M. Sabatini, S. H. Li, C. A. Ross, and S. H. Snyder. 1996. Lymphocyte apoptosis: mediation by increased type 3 inositol 1,4,5-trisphosphate receptor. Science 273:503.
31. Szalai, G., R. Krishnamurthy, and G. Hajnoczky. 1999. Apoptosis driven by IP(3)-linked mitochondrial calcium signals. EMBO J. 18:6349.
32. Kobayashi, S. D., J. M. Voyich, G. A. Somerville, H. L. Malech. J. M. Musser, and F. R. DeLeo. 2003. An apoptosis differentiation program in human polymorphonuclear leukocytes facilitates resolution of inflammation. J. Leukocyte Biol. 73:315.
33. Boyum, A. 1968. Isolation of mononuclear cells and granulocytes from human blood: isolation of mononuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g. Scand. J. Clin. Lab Invest. Suppl. 97:77
34. Liles, W. C., P. A. Kiener, J. A. Ledbetter, A. Aruffo, and S. J. Klebanoff. 1996. Differential expression of Fas (CD95) and Fas ligand on normal human phagocytes: implications for the regulation of apoptosis in neutrophils. J. Exp. Med. 184:429.
35. Hiraoka, W., N. Vazquez, W. Nieves-Neira, S. J. Chanock, and Y. Pommier. 1998. Role of oxygen radicals generated by NADPH oxidase in apoptosis induced in human leukemia cells. J. Clin. Invest. 102:1961.
36. Jones, J., and B. P. Morgan. 1995. Apoptosis is associated with reduced expression of complement regulatory molecules, adhesion molecules and other receptors on polymorphonuclear leukocytes: functional relevance and role in inflammation. Immunology 86:651.
37. Ahuja, S. K., and P. M. Murphy. 1996. The CXC chemokines growth-regulated oncogene (GRO) α, GROβ, GROγ, neutrophil-activating peptide-2, and epithelial cell-derived neutrophil-activating peptide-78 are potent agonists for the type B, but not the type A, human interleukin-8 receptor. J. Biol. Chem. 271:20545.
38. Domin, J., F. Pages, S. Volinia, S. E. Rittenhouse, M. J. Zvelebil, R. C. Stein, and M. D. Waterfield. 1997. Cloning of a human phosphoinositide 3-kinase with a C2 domain that displays reduced sensitivity to the inhibitor wortmannin. Biochem. J. 326:139.
39. Jayaraman, T., and A. R. Marks. 1997. T cells deficient in inositol 1,4,5-trisphosphate receptor are resistant to apoptosis. Mol. Cell. Biol. 17:3005.
40. Whyte, M. K., L. C. Meagher, J. MacDermot, and C. Haslett. 1993. Impairment of function in aging neutrophils is associated with apoptosis. J. Immunol. 150:5124.
41. Muller, W. A., S. A. Weigl, X. Deng, and D. M. Phillips. 1993. PECAM-1 is required for transendothelial migration of leukocytes. J. Exp. Med. 178:449.
42. Hart, S. P., J. A. Ross, K. Ross. C. Haslett, and I. Dransfield. 2000. Molecular characterization of the surface of apoptotic neutrophils: implications for functional downregulation and recognition by phagocytes. Cell Death Differ. 7:493.
43. Samanta, A. K., J. J. Oppenheim, and K. Matsushima. 1990. Interleukin 8 (monocyte-derived neutrophil chemotactic factor) dynamically regulates its own receptor expression on human neutrophils. J. Biol. Chem. 265:183.
44. Lloyd, A. R., A. Biragyn, J. A. Johnston, D. D. Taub, L. Xu, D. Michiel, H. Sprenger, J. J. Oppenheim, and D. J. Kelvin. 1995. Granulocyte-colony stimulating factor and lipopolysaccharide regulate the expression of interleukin 8 receptors on polymorphonuclear leukocytes. J. Biol. Chem. 270:28188.
45. Baggiolini, M. B. Dewald, and B. Moser. 1994. Interleukin-8 and related chemotactic cytokines - CXC and CC chemokines. Adv. Immunol. 55:97.
46. Dinarello, C. A. 1999. Interleukin-1: a pro-inflammatory cytokine. In Inflammation: Basic Principles and Clinical Correlates. 3rd Ed. Gallin, J. I., and R. Snyderman, eds. Philadelphia, PA, Lippincott-Williams and Wilkins, p. 443.
47. Kobayashi, Y., J. J. Oppenheim, and K. Matsushima. 1991. Human pre-interleukin 1 α and β: structural features revealed by limited proteolysis. Chem. Pharm. Bull. 39:1513.
48. Greenfeder, S. A., P. Nunes, L. Kwee, M. Labow, R. A. Chizzonite, and G. Ju. 1995. Molecular cloning and characterization of a second subunit of the interleukin 1 receptor complex. J. Biol. Chem. 270:13757.
49. Stephens, L. R., L. T. Hughes, and R. F. Irvine. 1991. Pathway of phosphatidylinositol(3,4.5)-trisphosphate synthesis in activated neutrophils. Nature 351:33.